Back
Novo Nordisk A/S Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
9
NVO
Novo Nordisk A/S
Last Price:
$39.61
Seasonality Move:
9.7%
7 Day Trial
ALL ACCESS PASS
$
7
Novo Nordisk A/S Stock Forecast
-
Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 22% based on the past 44 years of stock performance.
-
Novo Nordisk A/S has risen higher in 32 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
-
Is Novo Nordisk A/S Stock Undervalued?The current Novo Nordisk A/S [NVO] share price is $39.63. The Score for NVO is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk A/S Stock Go Up Next Year?
-
Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 22% based on the past 44 years of stock performance.
Novo Nordisk A/S Stock Rating
Sell
9
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S overpriced?
-
Novo Nordisk A/S has risen higher in 32 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
Novo Nordisk A/S Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
93.80
52-Week Low:
39.34
Prediction Charts
Market Cap:
176.2B
Price in USD:
39.63
Volume:
98.7M
Beta:
0.48
Technical Analysis
SMA50:
53.25
SMA100:
52.40
SMA200:
57.73
52-Wk Change:
-55.01%
Stock Predictions
-
Is Novo Nordisk A/S stock public?Yes, Novo Nordisk A/S is a publicly traded company.
-
What is the Novo Nordisk A/S stock quote today?The Novo Nordisk A/S stock price is 39.63 USD today.
-
How to buy Novo Nordisk A/S stock online?You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-3 | 58.35 | 50.30 | 58.64 | 49.96 |
| Feb-4 | 47.95 | 47.19 | 49.10 | 46.47 |
| Feb-5 | 45.05 | 43.34 | 45.67 | 43.24 |
| Feb-6 | 46.37 | 47.64 | 47.74 | 45.84 |
| Feb-9 | 50.13 | 49.37 | 51.09 | 49.01 |
| Feb-10 | 50.02 | 49.12 | 50.46 | 48.98 |
| Feb-11 | 48.73 | 48.74 | 48.96 | 48.08 |
| Feb-12 | 48.85 | 48.93 | 50.07 | 48.12 |
| Feb-13 | 49.30 | 49.57 | 49.84 | 49.20 |
| Feb-17 | 49.11 | 49.37 | 49.85 | 48.68 |
| Feb-18 | 48.84 | 49.23 | 49.36 | 48.63 |
| Feb-19 | 48.72 | 48.45 | 48.77 | 48.18 |
| Feb-20 | 47.69 | 47.42 | 47.75 | 47.03 |
| Feb-23 | 40.19 | 39.63 | 41.09 | 39.34 |
Novo Nordisk A/S Earnings
Novo Nordisk A/S Earnings Report: Per Share Novo Nordisk A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk A/S Forecast Revenue Growth
Novo Nordisk A/S Stock Analysis: Historical quarterly revenues per share for Novo Nordisk A/S and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $142.46 per share, and a decrease next year of $0.03 per share.
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.